author-photo

Corinne Delcambre

Institut Gustave Roussy

76

Papers

1443

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
A single-arm multicenter phase II trial of doxorubicin (Doxo) in combination with trabectedin (Trab) given as first-line treatment to patients with metastatic/advanced uterine (U-LMS) and soft tissue leiomyosarcoma (ST-LMS): Final results of the LMS-02 study.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Optimisation of chemotherapy prescription and preparation in an ambulatory unit: Validation of the OPTIMA program

2019 European Journal of Cancer Care
Show All
- Source
- Cite
- Save
Citations (1)
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib (REG) in patients (pts) with nonadipocytic soft tissue sarcoma (STS) previously treated with pazopanib (PAZ).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Multidisciplinary treatment of 99 adult osteosarcoma (OST) patients (pts) with synchronous and metachronous metastases (mets): A retrospective series of the French Sarcoma Group (FSG).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Methotrexate–Etoposide–Ifosfamide Compared with Doxorubicin–Cisplatin–Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18–25 Years

2019 Journal of adolescent and young adult oncology
Show All
- Source
- Cite
- Save
Citations (4)
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

2019 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (121)
Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy

2018 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (10)
Results of randomized, placebo (PL)-controlled phase II study evaluating efficacy and safety of regorafenib (REG) in patients (pts) with metastatic osteosarcoma (metOS), on behalf of the French Sarcoma Group (FSG) and Unicancer.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Results of a prospective randomized phase III T-SAR trial comparing trabectedin (T) vs best supportive care (BSC) in patients with pretreated advanced soft tissue sarcoma (ASTS): A French Sarcoma Group (FSG) trial.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)